Regulation of Myc-dependent apoptosis by p53, c-Jun N-terminal kinases/stress-activated protein kinases, and Mdm-2

Cell Growth and Differentiation

Volumn 8, Issue 7, 1997, Pages 731-742

  Yu, Ker ^a,b   Ravera, Christina P ^a   Chen, Ying Nan P ^a   McMahon, Gerald ^a,c  

^a Sandoz Pharma Ltd   (Switzerland)

^b PFIZER INC   (United States)

^c SUGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; NOCODAZOLE; PROTEIN KINASE; PROTEIN P53; VINBLASTINE;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL TRANSFORMATION; CONTROLLED STUDY; ENZYME REGULATION; FIBROBLAST CULTURE; GENE OVEREXPRESSION; GENETIC TRANSFECTION; NONHUMAN; ONCOGENE C JUN; ONCOGENE MYC; PRIORITY JOURNAL; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOOD; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL LINE; DOXORUBICIN; ENZYME ACTIVATION; FIBROBLASTS; GENE EXPRESSION; GENES, MYC; GENES, P53; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; NOCODAZOLE; NUCLEAR PROTEINS; OSTEOSARCOMA; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; RATS; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; VINBLASTINE;

ANIMALIA;

EID: 0030791513     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Marcu, K., Bossone, S., and Patel, A. Myc function and regulation. Annu. Rev. Biochem., 61: 809-860, 1992.
2. Blackwood, E. M., Kretzner, L., and Eiseman, R. N. Myc and Max function as a nucleoprotein complex. Curr. Opin. Genet. Dev., 2: 227-235, 1992.
3. Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L Z., and Hancock, D. C. Induction of apoptosis in fibroblasts by c-myc protein. Cell, 69: 119-128, 1992.
4. Shi, Y., Glynn, J. M., Guilbert, L. J., Cotter, T. G., Bissonnette, R. P., and Green, D. R. Role of c-myc in activation-induced apoptotic cell death in T cell hybridomas. Science (Washington DC), 257: 212-214, 1992.
5. Sakamuro, D., Eviner, V., Elliott, K., Showe, L., White, E., and Prendergast, G. c-Myc induces apoptosis in epithelial cells by both p53-dependent and p53-independent mechanisms. Oncogene, 11: 2411-2418, 1995.
6. Hermeking, H., and Eirk, D. Mediation of c-myc-induced apoptosis by p53. Science (Washington DC), 265: 2091-2093, 1994.
7. Wagner, A. J., Kokontis, J. M., and Hay, N. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21 waf1/cip1. Genes Dev., 8: 2817-2830, 1994.
8. Debbas, M., and White, E. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev., 7: 546-554, 1993.
9. Lowe, S. H., and Ruley, H. E. Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes Dev., 7: 535-545, 1993.
10. Qin, X. Q., Livingston, D. M., Kaelin, W, G., and Adams, P. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. USA, 91: 10918-10922, 1994.
11. Wu, X., and Levine, A. p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. USA, 91: 3602-3606, 1994.
12. Chen, J., Wu, X., Lin, J., and Levine, A. Mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein. Mol. Cell. Biol., 16: 2445-2452, 1996.
13. Momand, J., Zambetti, G. P., Olson, D. C., George, D., and Levine, A. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell, 69: 1237-1245, 1992.
14. Levine, A. J., Momand, J., and Finlay, C. A. The p53 tumor suppressor gene. Nature (Lond.), 351: 453-456, 1991.
15. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C. C. p53 mutations in human cancers. Science (Washington DC), 253: 49-53, 1991.
16. Shaw, P., Bovey, R., Tardy, S., Sahli, R., Sordat, B., and Costa, J. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc. Natl. Acad. Sci. USA, 89: 4495-4499, 1992.
17. Yonish-Rouach, E., Grunwald, D., Wilder, S., Kimchi, A., May, E., Lawrence, J. J., May, P., and Oren, M. p53 mediated cell death: relationship to cell cycle control. Mol. Cell. Biol., 13: 1415-1423, 1993.
18. Ramqvist, T., Magnusson, K. P., Wang, Y., Szekely, L., Klein, G., and Wiman, K. G. Wild-type p53 induces apoptosis in a Burkitt lymphoma (BL) line that carries mutant p53. Oncogene, 8: 1495-1450, 1993.
19. Wang, Y., Ramqvist, T., Szekely, L., Axelson, H., Klein, G., and Wiman, K. G. Reconstitution of wild-type p53 expression triggers apoptosis in a p53-negative v-myc retrovirus-induced T-cell lymphoma line. Cell Growth & Differ., 4: 467-473, 1993.
20. Fujiwara, T., Grimm, E. A., Mukhopadhyay, T., Cai, D. W., Owen-Schaub, L. B., and Roth, J. A. A retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis. Cancer Res., 53: 4129-4133, 1993.
21. Fujiwara, T., Grimm, E. A., Mukhopadhyay, T., Zhang, W. W., Owen-Schaub, L. B., and Roth, J. A. Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene. Cancer Res., 54: 2287-2291, 1994.
22. Saito, Y., and Ogawa, K. Wild-type p53 and c-myc co-operation in generating apoptosis of a rat hepatocellular carcinoma cell line (FAA-HTC1). Oncogene, 11: 1013-1018, 1995.
23. Lane, D. P. p53, guardian of the genome. Nature (Lond.), 358: 15-16, 1992.
24. Cross, S. M., Sanchez, C. A., Morgan, C. A., Schimke, M. K., Ramel, S., Idzerda, R. L., Raskind, W. H., and Reid, B. J. A p53-dependent mouse spindle checkpoint. Science (Washington DC), 267: 1353-1356, 1995.
25. Symonds, H., Krall, L., Remington, L., Saenz-Robles, M., Lowe, S., Jacks, T., and Dyke, T. V. p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell, 78: 703-711, 1994.
26. Lowe, S., Jacks, T., Housman, D. E., and Ruley, H. E. Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells. Proc. Natl. Acad. Sci. USA, 91: 2026-2030, 1994.
27. Fisher, D. E. Apoptosis in cancer therapy: crossing the threshold. Cell, 78: 539-542, 1994.
28. Karin, M. The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem., 270: 16483-16486, 1995.
29. Hibi, M., Lin, A., Smeal, T., Minden, A., and Karin, M. Identification of an oncoprotein and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev., 7: 2135-2148, 1993.
30. Derijard, B., Hibi, M., Wu, I-H., Barrett, T., Su, B., Deng, T., Karin, M., and Davis, R. JNK1, a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell, 76: 1025-1037, 1994.
31. Kyriakis, J., Banerjee, P., Nikolakaki, E., Dai, T., Rubie, E., Ahmad, M., Avruch, J., and Woodgett, J. The stress-activated protein kinase subfamily of c-Jun kinases. Nature (Lond.), 369: 156-160, 1994.
32. Han, J., Lee, J., Bibbs, L., and Ulevitch, R. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science (Washington DC), 265: 808-811, 1994.
33. Cobb, M., and Goldsmith, E. How MAP kinases are regulated. J. Biol. Chem., 270: 14843-14846, 1995.
34. Sanchez, I., Hughes, R., Mayer, B., Yee, K., Woodgett, J., Avruch, J., Kyriakis, J., and Zon, L. Role of SAPK/ERK kinase 1 in stress-activated pathway regulating transcription factor c-Jun. Nature (Lond.), 372: 794-798, 1994.
35. Yan, M., Dai, T., Deak, J., Kyriakis, J., Zon, L., Woodgett, J., and Templeton, D. Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activator SEK1. Nature (Lond.), 372: 798-800, 1994.
36. Xia, Z., Dickens, M., Raingeaud, J., Davis, R., and Greenberg, M. Opposing effects of ERK and JNK/p38 MAP kinases on apoptosis. Science (Washington DC), 270: 1326-1331, 1995.
37. Chen, Y., Meyer, C., and Tan, T-H. Persistent activation of c-Jun N-terminal kinase 1 (JNK1) in γ radiation-induced apoptosis. J. Biol. Chem., 271: 631-634, 1996.
38. Verheij, M., Bose, R., Lin, X., Yao, B., Jarvis, B., Grant, S., Birrer, M., Szabo, E., Zon, L., Kyriakis, J., Haimovitz-Friedman, A., Fuks, Z., and Kolesnick, R. Requirement for ceramide-initiated SAPK/JNK signaling in stress-induced apoptosis. Nature (Lond.), 380: 75-79, 1996.
39. Cuvillier, O., Pirianov, G., Kleuser, B., Vanek, P., Coso, O., Gutkind, S., and Spiegel, S. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature (Lond.), 381: 800-803, 1996.
40. Gossen, M., and Bujard, H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA, 89: 5547-5551, 1992.
41. Zhan, Q., Fan, S., Bae, I., Guillouf, C., Liebermann, D. A., O'Connor, P. M., and Fornace, A. J. Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis. Oncogene, 9: 3743-3752, 1994.
42. Gory, A., Owen, T., Barltrop, J., and Cory, J. Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun., 3: 207-212, 1991.
43. Dubs-Poterszman, M-C., Tocque, B., and Wasylyk, B. MDM2 transformation in the absence of p53 and abrogation of the p107 G1 cell-cycle arrest. Oncogene, 11: 2445-2449, 1995.
44. Roy, B., Beamon, J., Balint, E., and Reisman, D. Transactivation of the human p53 tumor suppressor gene by c-myc/max contributes to elevated mutant p53 expression in some tumors. Mol. Cell. Biol., 14: 7805-7815, 1994.
45. Fernandez, A., Marin, M. C., McDonnell, T., and Ananthaswamy, H. N. Differential sensitivity of normal and Ha-ras-transformed C3H mouse embryo fibroblasts to tumor necrosis factor: induction of bcl-2, c-myc, and manganese superoxide dismutase in resistant cells. Oncogene, 9: 2009-2017, 1994.
46. Tanaka, N., Ishihara, M., Kitagawa, M., Harada, H., Kimura, T., Matsuyama, T., Lamphier, M. S., Aizawa, S., Mak, T. W., and Taniguchi, T. Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell, 77: 829-839, 1994.
47. Lowe, S. W., Ruley, H. E., Jacks, T., and Housman, D. E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74: 957-967, 1993.
48. Lotem, J., and Sachs, L. Regulation by bcl-2, c-myc, and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation-competent and -defective myeloid leukemic cells. Cell Growth & Differ., 4: 41-47, 1993.
49. Lowe, S. W., Bodis, S., McClatchey, A., Remington, L., Ruley, H. E., Fisher, D. E., Housman, D. E., and Jacks, T. p53 status and the efficacy of cancer therapy in vivo. Science (Washington DC), 266: 807-810, 1994.
50. Xia, F., Wang, X., Wang, Y., Tsang, N., Yandell, D. W., Kelsey, K. T., and Liber, H. L. Altered p53 status correlates with differences in sensitivity to radiation-induced mutation and apoptosis in two closely related human lymphoblast lines. Cancer Res., 55: 12-15, 1995.
51. Ladanyi, M., Cha, C., Lewis, R., Jhanwar, S. C., Huvos, A. G., and Healey, J. H. mdm-2 gene amplification in metastatic osteosarcoma. Cancer Res., 53: 16-18, 1993.
52. Martin, K., Trouche, D., Hagemeier, C., Sorensen, T., La Thangue, N., and Kouzarides, T. Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein. Nature (Lond.), 375: 691-694, 1995.
53. Xiao, Z., Chen, J., Levine, A., Modjtahedi, N., Xing, J., Sellers, W., and Livingston, D. Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature (Lond.), 375: 694-698, 1995.
54. Kerr, J. F. R., Winterford, C. M., and Harmon, B. V. Apoptosis, its significance in cancer and cancer therapy. Cancer (Phila.), 73: 2013-2026, 1994.
55. Colby, W. W., Chen, E. Y., Smith, D. H., and Levinson, A. D. Identification and nucleotide sequence of a human locus homologous to the v-myc oncogene of avian myelocytomatosis virus MC29. Nature (Lond.), 301: 722-725, 1983.
56. Baker, S. J., Markowitz, S., Fearon, E. R., Willson, J. K. V., and Vogelstein, B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science (Washington DC), 249: 912-915, 1990.
57. Cano, E., Hazzalin, C. A., and Mahadevan, L. C. Anisomycin-activated protein kinase p45 and p55 but not mitogen-activated protein kinases ERK-1 and -2 are implicated in the induction of c-fos and c-jun. Mol. Cell. Biol., 14: 3752-3762, 1994.
58. Raingeaud, J., Gupta, S., Rogers, S. J., Dickens, M., Han, J., Ulevitch, R. J., and Davis, R. J. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem., 270: 7420-7426, 1995.